Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Helyezés a részvények között
#4851
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Részvényárfolyam
$2.55
Piaci kapitalizáció
$3.05B
Változás (1 nap)
3.33%
Változás (1 év)
-11.84%
Ország
CN
Kereskedés Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategória
Healthcare
Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) P/B aránya
P/B arány ekkor: October 2026 TTM: 0.60
Jilin Aodong Pharmaceutical Group Co., Ltd. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 0.60. 2023 végén ez az arány 0.63 volt.
P/B arány története a(z) Jilin Aodong Pharmaceutical Group Co., Ltd. esetén 2000 és 2026 között
P/B arány az év végén
| Év | P/B arány | Változtassa meg |
|---|---|---|
| 2026 (TTM) | 0.60 | -13.67% |
| 2024 | 0.70 | 11.71% |
| 2023 | 0.63 | -4.03% |
| 2022 | 0.65 | -22.83% |
| 2021 | 0.85 | 3.64% |
| 2020 | 0.82 | -5.45% |
| 2019 | 0.86 | 8.73% |
| 2018 | 0.79 | -38.62% |
| 2017 | 1.29 | -11.82% |
| 2016 | 1.47 | -7.84% |
| 2015 | 1.59 | -35.53% |
| 2014 | 2.47 | 63.97% |
| 2013 | 1.51 | -4.54% |
| 2012 | 1.58 | 1.57% |
| 2011 | 1.55 | -42.84% |
| 2010 | 2.72 | -39.78% |
| 2009 | 4.51 | 103.81% |
| 2008 | 2.21 | -73.01% |
| 2007 | 8.20 | 53.64% |
| 2006 | 5.34 | 362.58% |
| 2005 | 1.15 | -5.59% |
| 2004 | 1.22 | 8.05% |
| 2003 | 1.13 | -35.55% |
| 2002 | 1.76 | -6.22% |
| 2001 | 1.87 | -38.50% |
| 2000 | 3.04 | 0.00% |
P/B arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/B arány | P/B arány különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 734.19% |
IN
|
